Critical Path Institute Grants $249,719 to Odylia Therapeutics to Propel Gene Therapy for USH1C-Related Vision Loss
In an ambitious effort to combat a rare genetic disorder known as Usher Syndrome Type 1C (USH1C), the Critical Path ...
In an ambitious effort to combat a rare genetic disorder known as Usher Syndrome Type 1C (USH1C), the Critical Path ...
In a groundbreaking advancement in the field of ophthalmic gene therapy, researchers have achieved a significant milestone in the treatment ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine